HLA-G is an inhibitory checkpoint molecule, which is highly expressed in gynecological cancers, such as cervical cancer (3, 4, 7–10), ovarian cancer (20), breast cancer (21, 22), and endometrial cancer (23). This evidence concerns the gene HLA-G and cervical carcinoma.